Literature DB >> 2581277

Prevention of strychnine-induced seizures and death by the N-methylated glycine derivatives betaine, dimethylglycine and sarcosine.

W J Freed.   

Abstract

Betaine (N,N,N-trimethylglycine) and N,N-dimethylglycine have been reported to have anticonvulsant properties in animals. The purpose of the present study was to determine whether these compounds can antagonize strychnine-induced seizures when administered intraperitoneally and to compare their effects with those of sarcosine (N-methylglycine) and glycine. Betaine, N,N-dimethylglycine and sarcosine were equipotent in decreasing the incidence of seizures and death, causing a 38 to 72 percent decrease in the incidence of seizures and death at a dosage of 5 mmole/kg. Glycine had no effect. Thus anticonvulsant activity is conferred to glycine by a single N-methylation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581277     DOI: 10.1016/0091-3057(85)90288-6

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

1.  Folate in demethylation: the crystal structure of the rat dimethylglycine dehydrogenase complexed with tetrahydrofolate.

Authors:  Zigmund Luka; Svetlana Pakhomova; Lioudmila V Loukachevitch; Marcia E Newcomer; Conrad Wagner
Journal:  Biochem Biophys Res Commun       Date:  2014-05-22       Impact factor: 3.575

2.  Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice.

Authors:  Jen-Cheng Lin; Mei-Yi Lee; Ming-Huan Chan; Yi-Chyan Chen; Hwei-Hsien Chen
Journal:  Psychopharmacology (Berl)       Date:  2016-06-30       Impact factor: 4.530

3.  MDL 27,531 selectively reverses strychnine-induced seizures in mice.

Authors:  J H Kehne; J M Kane; F P Miller; H J Ketteler; D L Braun; Y Senyah; S F Chaney; A Abdallah; M W Dudley; A M Ogden
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

4.  Effects of sarcosine and N, N-dimethylglycine on NMDA receptor-mediated excitatory field potentials.

Authors:  Mei-Yi Lee; Yi-Ruu Lin; Yi-Shu Tu; Yufeng Jane Tseng; Ming-Huan Chan; Hwei-Hsien Chen
Journal:  J Biomed Sci       Date:  2017-02-28       Impact factor: 8.410

5.  Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease.

Authors:  Daniel Stoessel; Claudia Schulte; Marcia C Teixeira Dos Santos; Dieter Scheller; Irene Rebollo-Mesa; Christian Deuschle; Dirk Walther; Nicolas Schauer; Daniela Berg; Andre Nogueira da Costa; Walter Maetzler
Journal:  Front Aging Neurosci       Date:  2018-03-05       Impact factor: 5.750

6.  Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms.

Authors:  Yasuhiko Kato; Hitoshi Kuwabara; Takashi Okada; Toshio Munesue; Seico Benner; Miho Kuroda; Masaki Kojima; Walid Yassin; Yosuke Eriguchi; Yosuke Kameno; Chihiro Murayama; Tomoko Nishimura; Kenji Tsuchiya; Kiyoto Kasai; Norio Ozaki; Hirotaka Kosaka; Hidenori Yamasue
Journal:  Mol Autism       Date:  2021-02-23       Impact factor: 7.509

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.